Carson Allaria Wealth Management, Ltd. Gilead Sciences, Inc. Transaction History
Carson Allaria Wealth Management, Ltd.
- $169 Million
- Q3 2024
A detailed history of Carson Allaria Wealth Management, Ltd. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Carson Allaria Wealth Management, Ltd. holds 120 shares of GILD stock, worth $11,041. This represents 0.01% of its overall portfolio holdings.
Number of Shares
120
Previous 358
66.48%
Holding current value
$11,041
Previous $24,000
58.33%
% of portfolio
0.01%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding GILD
# of Institutions
1,926Shares Held
992MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$11.1 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.6 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.04 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.69 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.54 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $115B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...